Biosimilars are the biologic equivalent of generic drugs - highly similar, proven safe, and significantly cheaper. Learn how they compare to authorized generics, why adoption is slow, and what’s changing in 2026.
Biosimilars are the biologic equivalent of generic drugs - highly similar, proven safe, and significantly cheaper. Learn how they compare to authorized generics, why adoption is slow, and what’s changing in 2026.